wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47429093-6016A458-3A1A-4AC0-BCE3-AC1F7574EC2E
Q47429093-6016A458-3A1A-4AC0-BCE3-AC1F7574EC2E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47429093-6016A458-3A1A-4AC0-BCE3-AC1F7574EC2E
MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma.
P2860
Q47429093-6016A458-3A1A-4AC0-BCE3-AC1F7574EC2E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47429093-6016A458-3A1A-4AC0-BCE3-AC1F7574EC2E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
86483ef2662cb171babeafcea48ce3883a7081be
P2860
A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study.